⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqCM

VRDN

Viridian Therapeutics, Inc.

Healthcare · Biotechnology

22.37USD

-0.4500 (-1.97%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on VRDN.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 22.37
P/E—
Dvd Ind Yld0.0%
P/B3.83
P/S35.6
Curr EV/T12M EBITDA-4.7
Mkt Cap (USD)2.5B
Curr EV (USD)1.9B
2)

Per Share Data

EPS T12M-3.49
DPS—
Bk Val Per Sh4.98
Rev/Sh0.87
Cash/Sh8.66
Curr Shares Out113.3M
FCF/Sh-4.11
3)

Cash Flow Analysis

P/CF-7.6
Curr P/FCF-7.6
CF/NI0.9
Dvd P/O—
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-468.7%
Eff Interest Rate75.4%
4)

Growth Potential

Dil EPS 1Y Gr-31.1%
Cap 1Y Gr4.3%
BPS 1Y Gr-19.8%
R&D To Sales30.2%
Retention Rate—
Rev 1Y Gr23359.9%
FCF 1Y Gr-18.9%
Assets 1Y Gr21.1%
5)

Profitability

EBITDA-0.4B
EBIT-0.4B
Operating Margin-569.7%
Pretax Margin—
Net Margin-544.1%
ROA-46.1%
ROE-65.7%
ROC—
Asset Turnover0.08
6)

Structure

Current Ratio16.95
Quick Ratio16.56
Debt/Assets2.7%
Debt/Com Eq4.4%
Net Debt/EBITDA0.34
Tot Debt/Capital4.2%
Gross Margin4.3%
EBIT/Int Exp-26.0

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.